Dr. Gunay Uludag Uludag Kirimli, MD

Dr. Uludag Kirimli practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Uludag Kirimli's NPI, 1932806973, was assigned on February 9, 2023. Dr. Uludag Kirimli holds Washington license TR61523908.

Dr. Uludag Kirimli's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Uludag Kirimli's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Uludag Kirimli to 1 more hospital and 2 medical groups, each named with a free account. Dr. Uludag Kirimli's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uludag Kirimli practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Uludag Kirimli's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Uludag Kirimli is licensed in Washington.

CMS data shows 54 Medicare services from Dr. Uludag Kirimli across 2 procedure codes in 2024, for 60 Medicare patients. Medicare paid $2,656 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Uludag Kirimli in 2024. The largest group is 65 to 74, with 33 patients. 70% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uludag Kirimli's median patient age at 54, with 55% women.

In 2024, Dr. Uludag Kirimli wrote 116 Medicare Part D claims for 52 patients. 55% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $9,663 in total drug cost.

Dr. Uludag Kirimli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Uludag Kirimli, published from 2019 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Uveitis. Dr. Uludag Kirimli's most frequent co-authors are Quan Dong Nguyen, MD, Diana V. Do, MD and Irmak Karaca, MD.

CMS Open Payments shows 21 general payments to Dr. Uludag Kirimli from 2 drug and device companies in 2025. Grants make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $66,654.